-
ctDNA Testing in Breast CancerExplore the role of molecular monitoring in early breast cancer.
sponsored by Natera
-
Beyond the Diagnosis: Metastatic Breast Cancer and ADCsDiscover how patients and providers are navigating treatments for metastatic breast cancer, including triple-negative breast cancer.
sponsored by Gilead and Kite Oncology
CAR T-cell therapies and bispecific antibodies offer options for people with relapsed or refractory multiple myeloma.
by Jo Cavallo
-
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker -
Does Exercise Benefit Children With Cancer?New guidelines recommend children and adolescents with cancer get regular physical activity to mitigate side effects from treatment.
by Erin O’Donnell -
Can the CYP2D6 Gene Affect Tamoxifen’s Effectiveness?A recent analysis examined whether CYP2D6 metabolism influences tamoxifen response. The answer isn’t entirely clear.
by Ashley P. Taylor -
Even Brunch Feels Complicated After a Cancer DiagnosisResearch defines key behaviors for longevity in cancer survivors, but finding the balance between living by the rules and living your life isn’t always straightforward.
by Alexandra Frost
Support for Cancer Today has been provided in part by an independent educational grant from Merck & Co., Inc.
All editorial content is produced independently by the Cancer Today editorial team.
-
AACR OMB Statement and Call to ActionThe AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
-
AACR Cancer Disparities Progress ReportThe AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
The AACR Cancer Progress Report, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.
Support for Cancer Today has been provided in part by an independent educational grant from Merck & Co., Inc.
All editorial content is produced independently by the Cancer Today editorial team.
